Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Cardeon | CARDEO | 27. dec 2024 | 0.03 | 0.00 |
Careium AB | CARE | 27. dec 2024 | 30.70 | +1.66 |
Case | CASE | 27. dec 2024 | 17.20 | +2.38 |
Castellum | CAST | 27. dec 2024 | 120.85 | +1.05 |
Catella A | CATA | 27. dec 2024 | 26.00 | +0.78 |
Catella B | CATB | 27. dec 2024 | 26.95 | +0.56 |
Catena | CATE | 27. dec 2024 | 472.50 | +0.21 |
Catena Media | CTM | 27. dec 2024 | 3.79 | -4.05 |
Cavendish Hydrogen | CAVENO | 27. dec 2024 | 8.65 | -1.70 |
Cavotec SA | CCC | 27. dec 2024 | 16.75 | +1.52 |
CDON | CDON | 27. dec 2024 | 90.00 | -2.17 |
Cedergrenska | CEDER | 27. dec 2024 | 28.00 | +4.48 |
Cell Impact | CI | 27. dec 2024 | 0.15 | -2.26 |
CellaVision | CEVI | 27. dec 2024 | 217.50 | -1.58 |
Cereno Scientific B | CRNOB | 27. dec 2024 | 5.43 | +0.46 |
ChargePanel AB (publ) | CHARGE | 27. dec 2024 | 1.42 | 0.00 |
Checkin.com Group | CHECK | 27. dec 2024 | 14.00 | -2.44 |
Cheffelo | CHEF | 27. dec 2024 | 25.50 | +3.66 |
Chordate Medical Holding | CMH | 27. dec 2024 | 9.22 | -8.71 |
Chosa Oncology AB | CHOSA | 27. dec 2024 | 0.78 | +18.43 |
Cibus Nordic Real Estate | CIBUS | 27. dec 2024 | 171.70 | -0.09 |
Cinclus Pharma Holding AB | CINPHA | 27. dec 2024 | 20.50 | +2.24 |
Cinis Fertilizer AB | CINIS | 27. dec 2024 | 9.93 | -0.50 |
Cint Group | CINT | 27. dec 2024 | 13.05 | -1.06 |
CirChem | CIRCHE | 27. dec 2024 | 3.55 | -3.53 |
Circle Energy Sweden B | CIRCLEB | 27. dec 2024 | 0.00 | +50.00 |
Clas Ohlson B | CLASB | 27. dec 2024 | 210.00 | +0.38 |
Clavister Holding | CLAV | 27. dec 2024 | 2.36 | +0.43 |
Clean Motion | CLEMO | 27. dec 2024 | 0.30 | +1.33 |
Clemondo Group | CLEM | 27. dec 2024 | 7.08 | -3.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.